Celladon, Xencor bid for $155M in red-hot IPO market

Damian Garde

and have cast lines into the still-blazing biotech IPO scene, seeking a combined $ 155.3 million and betting that the recent Wall Street excitement for drug developers will hold firm.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS